Physician profile
Daniel M Paskowitz
NPI 1992907885
$607.77
in general payments reported to CMS, 2019-2025
10 companies · $56.98 in 2025
The $56.98 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.67 · 2020: $58.91 · 2021: $39.66 · 2022: $286 · 2023: $47.83 · 2024: $37.82 · 2025: $56.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.00 · Honoraria: $32.44 · Education: $17.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.00 |
| Honoraria | $32.44 |
| Education | $17.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $198.60 | 2022-2025 | Hydrus Microstent |
| Rxsight INC | $144.28 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Allergan, INC. | $66.85 | 2019 | |
| Omeros Corporation | $42.69 | 2020-2021 | |
| Apellis Pharmaceuticals, INC. | $37.82 | 2024 | Syfovre |
| Novartis Pharmaceuticals Corporation | $36.30 | 2019-2020 | |
| Coherus Oncology, INC. | $30.23 | 2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Glaukos Corporation | $17.60 | 2023 | Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Iaccess Precision Blade |
| Lumibird Medical INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Paskowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.